Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Camelia Spiridon
Observed names:
C. Spiridon,
Camelia I Spiridon,
Camelia I. Spiridon
Observed institution:
The University of Texas Southwestern Medical Center
OpenAlex ID:
A5072076133
Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo.
2002
·
Camelia I Spiridon
, Maria-Ana Ghetie
, et al.
·
PubMed
·
157
A Comparison of thein Vitroandin VivoActivities of IgG and F(ab′)2 Fragments of a Mixture of Three Monoclonal Anti-Her-2 Antibodies
2004
·
Camelia I. Spiridon
, Sarah Guinn
, et al.
·
Clinical Cancer Research
·
88
CD30, a marker to detect the high‐risk kidney transplant recipients
2008
·
Camelia Spiridon
, Afzal Nikaein
, et al.
·
Clinical Transplantation
·
29
Pre‐transplant level of soluble CD30 is associated with infection after heart transplantation
2007
·
Afzal Nikaein
, Camelia Spiridon
, et al.
·
Clinical Transplantation
·
21
Evaluation of Soluble CD30 as an Immunologic Marker in Heart Transplant Recipients
2006
·
C. Spiridon
, J. Hunt
, et al.
·
Transplantation Proceedings
·
16
The Generation and Anti-Myeloma Activity of a Chimeric Anti-CD54 Antibody, cUV3
2004
·
Joan E. Smallshaw
, Elaine Coleman
, et al.
·
Journal of Immunotherapy
·
11
23-P
2006
·
Afzal Nikaein
, Camelia Spiridon
, et al.
·
Human Immunology
Evaluation of HLA antibodies and sCD30 in heart transplantation
2005
·
C. Spiridon
, A. Nikaein
, et al.
·
Human Immunology
Show more works
View as search
Works count:
8
Citation count:
322
H-index:
6
I10-index:
6
Year
Topic
Type
